Impact of high-throughput screening in biomedical research
Owner/Developer: Nature Reviews Drug Discovery
|Country:||United States of America|
High-throughput screening (HTS) has been postulated in several quarters to be a contributory factor to the decline in productivity in the pharmaceutical industry. Moreover, it has been blamed for stifling the creativity that drug discovery demands. In this article, we aim to dispel these myths and present the case for the use of HTS as part of a proven scientific tool kit, the wider use of which is essential for the discovery of new chemotypes.
|Audience:||Scientists - Students - Industry - Researchers|
|User access:||Restricted access - Fee-based access|
|Relevance:||Replacement - Reduction|
|Purpose:||Method development - Fundamental studies - Documentation and information|
|Technology/Tools:||High throughput screening - High content screening|
Did you find what you were looking for?Yes, I found it! No, I did not!
Thanks for your feedback! Please note that we cannot respond unless you supply your email address.
What are you looking for?
Please give us your feedback so we can improve the information on the page. Thank you in advance for your help. Please add your email address if you would like a reply.Please contact us by email if you have any questions.